- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 17, Issue 18, 2017
Mini Reviews in Medicinal Chemistry - Volume 17, Issue 18, 2017
Volume 17, Issue 18, 2017
-
-
Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms
More LessIncreasing evidence suggests that stem cells, a small population of cells with unique selfrenewable and tumour regenerative capacity, are aiding tumour re-growth and multidrug resistance. Conventional therapies are highly ineffective at eliminating these cells leading to relapse of disease and formation of chemoresistance tumours. Cancer and stem cells targeted therapies that utilizes nanotherapeutics to delivery anti-can Read More
-
-
-
Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Authors: R. Soudy, N. Byeon, Y. Raghuwanshi, S. Ahmed, A. Lavasanifar and K. KaurCancer-targeting peptides as ligands for targeted delivery of anticancer drugs or drug carriers have the potential to significantly enhance the selectivity and the therapeutic benefit of current chemotherapeutic agents. Identification of tumor-specific biomarkers like integrins, aminopeptidase N, and epidermal growth factor receptor as well as the popularity of phage display techniques along with synthetic com Read More
-
-
-
Significance of Various Experimental Models and Assay Techniques in Cancer Diagnosis
Authors: Raksha Ghanghoria, Prashant Kesharwani and Narendra K. JainThe experimental models are of vital significance to provide information regarding biological as well as genetic factors that control the phenotypic characteristics of the disease and serve as the foundation for the development of rational intervention stratagem. This review highlights the importance of experimental models in the field of cancer management. The process of pathogenesis in cancer progression, invasion an Read More
-
-
-
Experimental Models for Evaluation of Nanoparticles in Cancer Therapy
Authors: Prashant Kesharwani, Raksha Ghanghoria and Narendra K. JainNanoparticles (NPs), the submicron-sized colloidal particles, have recently generated enormous interest among biomedical scientists, particularly in cancer therapy. A number of models are being used for exploring NPs safety and efficacy. Recently, cancer cell lines have explored as prominent experimental models for evaluating pharmacokinetic parameters, cell viability, cytotoxicity and drug efficacy in tumor cells. This review Read More
-
-
-
Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy
Authors: Rajeev Sharma, Nishi Mody, Udita Agrawal and S. P. VyasIn the recent years, theranostic nanomedicine based strategies have gained much attention in the field of oncology particularly, in the development of new generation cancer diagnostic and therapeutic tools. Today, various approaches have been developed for bioactive(s) targeting to predefined pathological sites, as well as for quantification of physiological processes and visualization. Significant attempts have been made to com Read More
-
-
-
Theranostic Potential of Targeted Nanoparticles for Brain Cancer
Authors: Ajita Bhatt, Ekta Gurnany, Anuj Modi, Arvind Gulbake and Aviral JainCancer is one of the most important causes of morbidity and mortality all across the world. On an average, every year approximately 238,000 new cases of brain and other central nervous system tumors are diagnosed around the world. Amongst all, tumors of brain account for nearly 85% to 90% of all primary central nervous system (CNS) tumors. Regardless of tremendous scientific efforts to develop newer diagnostic techni Read More
-
-
-
Nanoemulsion: A Novel Eon in Cancer Chemotherapy
Authors: Prashant Sahu, Debashree Das, Vikash K. Mishra, Varsha Kashaw and Sushil K. KashawCancer refers to an assemblage of lethal diseases characterized by abnormal growth of cells. The most celebrated adverse effects accredited to the cytotoxic class of anticancer agents are constructed owing to their inability to differentiate between the abnormally multiplying cancerous cell mass and the rapidly dividing healthy cells of the human body. Consequently, unknown targets chemotherapy for cancer play host to a Read More
-
-
-
Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
Authors: Pawan Tekchandani, Balak D. Kurmi and Shivani Rai PaliwalToday Cancer still remains a major cause of mortality and death worldwide, in humans. Chemotherapy, a key treatment strategy in cancer, has significant hurdles such as the occurrence of chemoresistance in cancer, which is inherent unresponsiveness or acquired upon exposure to chemotherapeutics. The resistance of cancer cells to an antineoplastic agent accompanied to other chemotherapeutic drugs with differ Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
